Learn About Familial Transthyretin Amyloidosis
- Familial transthyretin amyloidosis
- Amyloidosis Transthyretin related
- Amyloidosis, hereditary, transthyretin-related
- Familial amyloid polyneuropathy
- Hereditary ATTR amyloidosis
- TTR amyloid neuropathy
- Transthyretin amyloid neuropathy
- Transthyretin amyloid polyneuropathy
- Transthyretin amyloidosis
Duke Cardiology Clinic - Clinic 2F/2G
Michel Khouri is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Durham, North Carolina. Dr. Khouri is rated as a Distinguished provider by MediFind in the treatment of Familial Transthyretin Amyloidosis. His top areas of expertise are Cardiac Amyloidosis, Transthyretin Amyloid Cardiomyopathy, Heart Failure, Cardiac Ablation, and Orchiectomy. Dr. Khouri is currently accepting new patients.
Johns Hopkins Bayview Medical Center
Dr. Michael Polydefkis focuses on neuromuscular diseases, particularly peripheral nerve diseases. He has a special interest in diabetic and HIV-associated peripheral neuropathy. His expertise includes nerve conduction studies, electromyography and nerve, skin and muscle biopsy reading. Dr. Michael Polydefkis received his medical degree from The Johns Hopkins University School of Medicine. He then became a Howard Hughes Medical Institute research fellow before returning to Johns Hopkins to complete an internship and residency in internal medicine, residency in neurology and a fellowship in neuromuscular diseases. Dr. Polydefkis is rated as an Elite provider by MediFind in the treatment of Familial Transthyretin Amyloidosis. His top areas of expertise are Transthyretin Amyloidosis, Familial Transthyretin Amyloidosis, Primary Amyloidosis, and Peripheral Neuropathy.
Trustees Of Columbia University In The City Of New York
Mathew Maurer is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in New York, New York. Dr. Maurer is rated as an Elite provider by MediFind in the treatment of Familial Transthyretin Amyloidosis. His top areas of expertise are Cardiac Amyloidosis, Primary Amyloidosis, Transthyretin Amyloid Cardiomyopathy, Heart Transplant, and Transcatheter Aortic Valve Replacement (TAVR).
Summary: This is a follow-up study of subjects who received NTLA-2001 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy.
Summary: The aim of the study is to evaluate coronary flow reserve (CFR), index of microcirculatory resistance (IMR), and proportion of overt microvascular disease, defined as depressed CFR as well as elevated IMR in patients with cardiac amyloidosis. The second objective of this study is to compare results of non-invasive test including serum light chain amount, Doppler echocardiography with 2D strain, an...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center